StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 17, 2026, 04:33 PM

BGM Group Ltd. to Hold EGM for Share Capital Reduction and Consolidation

AI Summary

BGM Group Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for July 9, 2026. The primary agenda item is a significant share capital reduction and reorganization, which involves reducing the par value of all share classes to US$0.0001 and subdividing authorized but unissued shares. Shareholders will also vote on amendments to the company's Memorandum and Articles of Association (M&A) to reflect these changes. Additionally, the EGM will consider a potential share consolidation of up to 1-for-50, a post-consolidation share capital increase, and the adoption of new M&A documents.

Key Highlights

  • BGM Group Ltd. to hold Extraordinary General Meeting on July 9, 2026, to approve a share capital reduction and reorganization.
  • The proposal includes reducing the par value of shares to US$0.0001 and subdividing authorized but unissued shares.
  • Shareholders will vote on amending the company's Memorandum and Articles of Association (M&A) to reflect the changes.
  • A potential share consolidation of up to 1-for-50 is proposed, with the Board determining the final ratio.
  • The meeting will also consider a post-consolidation share capital increase and adoption of new M&A.